CSPG4P3Y

Across TCGA pan-cancer cohorts, CSPG4P3Y RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated CSPG4P3Y data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CSPG4P3Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CSPG4P3Y expression acts as an unfavorable survival marker.

KIRC, LUAD, and OV are the cancer types where CSPG4P3Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.271	0.722	.002	72	view →
LUAD	OS	Tertile	All	0.261	0.673	.014	54	view →
OV	DFS	Tertile	All	0.246	0.542	.014	54	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	54	view →
KIRP	OS	Tertile	All	0.216	0.904	<.001	45	view →
PRAD	OS	Tertile	All	0.540	0.990	<.001	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

CSPG4P3Y–KIRC (OS)

Open the KIRC breakdown →